.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
McKinsey
QuintilesIMS
Dow
Deloitte
AstraZeneca
Cipla
Boehringer Ingelheim
Federal Trade Commission
Mallinckrodt

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086678

« Back to Dashboard
NDA 086678 describes CYPROHEPTADINE HYDROCHLORIDE, which is a drug marketed by Morton Grove, Pliva, Superpharm, Sandoz, Tg United Labs, Naska, Patrin Pharma Inc, Par Pharm, Duramed Pharms Barr, Actavis Mid Atlantic, Impax Labs Inc, Kv Pharm, Zydus Pharms Usa Inc, Pioneer Pharms, Santos Biotech, Watson Labs, Appco Pharma Llc, Apnar Pharma Lp, Ivax Sub Teva Pharms, Halsey, Md Pharm, Lyne, Mylan, Apex Pharms Inc, Vitarine, Ascot, Ingenus Pharms Nj, Silarx Pharms Inc, Pharm Assoc, and Am Therap, and is included in thirty-three NDAs. It is available from twenty-five suppliers. Additional details are available on the CYPROHEPTADINE HYDROCHLORIDE profile page.

The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.

Summary for NDA: 086678

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Cerilliant
Baxter
Medtronic
Covington
Mallinckrodt
Teva
Johnson and Johnson
Dow
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot